This is a drug made by Hoffmann-La Roche which acts as a powerful and selective damaging allosteric modulator for team II of the metabotropic glutamate receptors (mGluR2/3), being equipotent at mGluR2 and mGluR3 but without having action at other mGluR subtypes.Whilst further more investigate is needed on the topic, the early identification of CEs